Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAutolus Therapeutics plc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 2 | -$0.08 | -$0.08 | -$0.08 |
| Q2 2024 | 2 | -$0.19 | -$0.19 | -$0.19 |
| Q3 2024 | 3 | -$0.21 | -$0.21 | -$0.21 |
| Q4 2024 | 5 | -$0.32 | -$0.05 | -$0.21 |
| Q1 2025 | 2 | -$0.23 | -$0.23 | -$0.23 |
| Q2 2025 | 1 | -$0.23 | -$0.23 | -$0.23 |
| Q3 2025 | 1 | -$0.22 | -$0.22 | -$0.22 |
| Q4 2025 | 1 | -$0.20 | -$0.20 | -$0.20 |
| Q1 2026 | 1 | -$0.21 | -$0.21 | -$0.21 |
| Q2 2026 | 1 | -$0.22 | -$0.22 | -$0.22 |
| Q3 2026 | 1 | -$0.18 | -$0.18 | -$0.18 |
| Q4 2026 | 1 | -$0.15 | -$0.15 | -$0.15 |
Autolus Therapeutics plc Earnings Date And Information
Autolus Therapeutics plc last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-0.31 earnings per share for the quarter, missing analysts' consensus estimates of $-0.21 by $0.1. The company had revenue of 0 for the quarter and had revenue of 1.70 M for the year. Autolus Therapeutics plc has generated $-1 earnings per share over the last year ($-1.2 diluted earnings per share) and currently has a price-to-earnings ratio of -2.23. Autolus Therapeutics plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 11th, 2025 based on prior year's report dates.
Autolus Therapeutics plc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.21 | -$0.31 | -0.1 | $155,000 | $0 |
| 08/08/2024 | Q2 2024 | -$0.19 | -$0.22 | -0.03 | $93,750 | $0 |
| 05/17/2024 | Q1 2024 | -$0.10 | -$0.24 | -0.14 | $10.09 M | |
| 03/21/2024 | Q4 2023 | -$0.44 | $1.78 M | |||
| 11/02/2023 | Q3 2023 | -$0.24 | -$0.26 | -0.02 | $624,800 | $406,000 |
| 08/03/2023 | Q2 2023 | -$0.22 | -$0.26 | -0.04 | $136,500 | $0 |
| 05/04/2023 | Q1 2023 | -$0.28 | -$0.23 | 0.05 | $1.29 M | |
| 03/07/2023 | Q4 2022 | -$0.31 | -$0.23 | 0.08 | $3.83 M | |
| 11/03/2022 | Q3 2022 | -$0.46 | -$0.47 | -0.01 | $144,286 | $2.37 M |
| 05/05/2022 | Q2 2022 | -$0.51 | -$0.46 | 0.05 | $240,556 | $0 |
| 05/05/2022 | Q1 2022 | -$0.51 | -$0.41 | 0.1 | $166,000 | |
| 03/10/2022 | Q4 2021 | -$0.49 | -$0.57 | -0.08 | $823,000 | |
| 11/03/2021 | Q3 2021 | -$0.50 | -$0.47 | 0.03 | $291,684 | $236,000 |
| 05/06/2021 | Q2 2021 | -$0.62 | -$0.47 | 0.15 | $212,154 | $1.51 M |
| 05/06/2021 | Q1 2021 | -$0.62 | -$0.53 | 0.09 | $269,000 | |
| 03/04/2021 | Q4 2020 | -$0.75 | -$0.69 | 0.06 | $-873,000 | |
| 11/05/2020 | Q3 2020 | -$0.66 | -$0.72 | -0.06 | $303,111 | $242,000 |
| 05/07/2020 | Q2 2020 | -$0.71 | -$0.62 | 0.09 | $327,000 | $293,000 |
| 05/07/2020 | Q1 2020 | -$0.71 | -$0.60 | 0.11 | $338,000 | |
| 03/03/2020 | Q4 2019 | -$0.71 | -$0.82 | -0.11 | $309,000 |
Autolus Therapeutics plc Earnings: FAQ's
When is Autolus Therapeutics plc's earnings date?
Autolus Therapeutics plc has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 11th, 2025 based off last year's report dates.
How can I listen to Autolus Therapeutics plc's earnings conference
call?
The conference call for Autolus Therapeutics plc's latest earnings report can be listened to online.
How can I read Autolus Therapeutics plc's conference call transcript?
The conference call transcript for Autolus Therapeutics plc's latest earnings report can be read online.
How much revenue does Autolus Therapeutics plc generate each year?
Autolus Therapeutics plc (:AUTL) has a recorded annual revenue of $1.70 M.
How much profit does Autolus Therapeutics plc generate each year?
Autolus Therapeutics plc (:AUTL) has a recorded net income of $1.70 M. Autolus Therapeutics plc has generated $-1.2 earnings per share over the last four quarters.
What is Autolus Therapeutics plc's price-to-earnings ratio?
Autolus Therapeutics plc (:AUTL) has a price-to-earnings ratio of -2.23 and price/earnings-to-growth ratio is 0.52.